Tianda Pharmaceutical Co., Ltd. is committed to the research, development, production and sale of pharmaceuticals, biotechnology and health products. Tianda Pharmaceutical is headquartered in Hong Kong, China, and has set up marketing centers in Shenzhen and Sydney, and has established R&D centers and pharmaceutical bases in Zhuhai and Kunming. Both pharmaceutical bases have obtained the new GMP certification issued by the China Food and Drug Administration, and the Zhuhai pharmaceutical base has also obtained GMP certification issued by the Australian Medicines Administration. Tianda Pharmaceutical Co., Ltd. is listed on the main board of the Hong Kong Stock Exchange, stock code: 00455. Tianda Group Co., Ltd. is the controlling shareholder of Tianda Pharmaceutical and holds 55.56% of the shares.
Clinical Trials
0
0 active
Approvals
3
Total approvals
Agencies
1
Regulatory bodies
Founded
1992
No trial phase data available
No trial data available
No trial data available
No news articles found
